Clinical Trial Update: 68Ga-JH04 PET/CT: Dosimetry and Biodistribution Studies [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial evaluating dosimetry and biodistribution of the radiotracer 68Ga-JH04 using PET/CT in malignant neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-JH04 (68Ga-JH04)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Malignant Neoplasm | EARLY_Phase 1 | Status: RECRUITING